HOME >> BIOLOGY >> NEWS
Deficits associated with prenatal alcohol exposure can be seen as early as infancy

  • Most of the research on prenatal alcohol exposure has been conducted with children.
  • A new study uses heart-rate data collected from six-month-old babies to examine the effects of alcohol consumption during pregnancy.
  • Even as early as infancy, slower processing speeds and arousal-regulation problems are apparent.

Most of the research on arousal and attention deficits caused by prenatal alcohol exposure has been conducted with children. An innovative new study, published in the March issue of Alcoholism: Clinical & Experimental Research, examines different components of attention through use of heart-rate data collected from six-month-old infants whose mothers drank during pregnancy. The findings indicate that slower processing speeds and arousal-regulation problems exist as early as infancy.

"The postnatal environment that children experience has a tremendous impact on children's cognitive status and attentional regulation skills," explained Julie A. Kable, assistant professor at Emory University School of Medicine and first author of the study. "Children of women who consume large amounts of alcohol during pregnancy and/or are substance abusers often experience family environments that do not support optimal development. As a result, when you examine older children it is often difficult to partition out the impact of the prenatal exposure with the impact of the postnatal environment. Assessments conducted closer in time to the insult provide a more accurate picture of the teratogenic effect."

"From a clinical point of view," added Sandra W. Jacobson, a professor in the department of psychiatry and behavioral neurosciences at Wayne State University School of Medicine, "tests such as the ones used in this study are important since it is critical to identify affected children as early in infancy as possible. Interventions are more likely to prove effective when implemented early in development and when sp
'"/>


14-Mar-2004


Page: 1 2 3 4

Related biology news :

1. Simian virus 40 not associated with non-Hodgkin lymphoma, study shows
2. IBD (Crohns, Colitis) joins cancer, inflammatory diseases in associated blood vessel growth
3. Common therapy for HIV associated with cervical abnormality regression
4. Milk consumption and calcium intake associated with lower colorectal cancer risk
5. Severe depression associated with greater number of nerve cells in thalamus region of brain
6. Calcium supplements associated with decreased risk of large bowel polyps
7. NIH funds new Boston College-Boston University study of B-1a cell associated with leukemia
8. Variation of gene associated with decreased risk of heart attack and stroke
9. Scientists identify six genes associated with survival in diffuse large B cell lymphoma
10. Chlamydiae infection may be associated with ocular adnexal lymphoma
11. Surprises found in gene variation associated with schizophrenia

Post Your Comments:
(Date:4/6/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... focused on the growing mobile commerce market, announced ... for MINIATURE, MULTI-PURPOSE ANTENNA METHOD AND SYSTEM ... NXT-ID introduces a new revolutionary method and system ... use of miniature antenna modules for multiple purposes ...
(Date:4/2/2015)... April 2, 2015 According to ... attributed to somewhat higher than 125 MSEK. This exceeds ... report 2014 that revenues for Q1 2015 would be ... reported for Q4 2014. The operating result for the ... The complete interim report will as previously communicated be ...
(Date:4/1/2015)... April 1, 2015   Medisafe ™, the leading ... across iOS and Android smartphones ... biofeedback into the platform to allow patients to track ... the first time, patients will be able to visualize ... impacts important biometrics, such as glucose levels and blood ...
Breaking Biology News(10 mins):NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4Fingerprint Cards Revises Revenues for Q1 2015 2Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2
(Date:4/21/2015)... Research and Markets ( http://www.researchandmarkets.com/research/9pknhj/complete_201516 ... "Complete 2015-16 Induced Pluripotent Stem Cell (iPSC) Industry ... Stem cell research and experimentation have been in ... cells have the unique ability to divide and ... them to differentiate into a wide variety of ...
(Date:4/21/2015)... , April 21, 2015  Scientists from the ... research organization, published a paper today outlining new ... microalgae called diatoms. The researchers, led by first ... author Philip Weyman , Ph.D., conclude that ... understanding of diatom genetics and thus facilitate advances ...
(Date:4/21/2015)... April 21, 2015 Ampio Pharmaceuticals, Inc. (NYSE ... investor call on Thursday, April 23, 4:30 p.m. ET. ... as follows: Investor call information: ... 789-4877 International toll number: (925) 418-7845 Participant Passcode: 32888538 ... Tina Amirkiai , tina.amirkiai@fleishman.com . ...
(Date:4/21/2015)... 2015  scPharmaceuticals, Inc., a privately held ... subcutaneous delivery, announced today that it has ... proprietary drug product, Furosemide Injection Solution, for ... heart failure. Concurrently with its ... patch pump.  The patch pump is designed ...
Breaking Biology Technology:Global Complete 2015-16 Induced Pluripotent Stem Cell (iPSC) Industry Report 2Scientists at the J. Craig Venter Institute Publish Paper Outlining Efficient Synthetic Biology Methods to Genetically Engineer Microalgae 2Scientists at the J. Craig Venter Institute Publish Paper Outlining Efficient Synthetic Biology Methods to Genetically Engineer Microalgae 3Ampio Announces Investor Call on Thursday, April 23, 4:30 p.m. ET 2scPharmaceuticals Announces Start of Pivotal Trial for Novel Furosemide Solution for Subcutaneous Delivery 2scPharmaceuticals Announces Start of Pivotal Trial for Novel Furosemide Solution for Subcutaneous Delivery 3
Cached News: